Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Datasea Announces Fiscal Year 2024 Financial Results with Revenue 6.6x that of 2023 Primarily due to Growth of its 5G AI Business 2024-09-26 21:45
Breakthrough Therapy Designation (BTD) for BioCity's SC0062, a selective endothelin type A (ETA) antagonist, granted by National Medical Products Administration for IgA nephropathy (IgAN) with proteinuria 2024-09-26 15:10
Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management 2024-09-26 02:00
The World First Liquid Formulation of Recombinant Botulinum Toxin Type A Has Obtained IND Approval by the FDA 2024-09-25 21:18
Bloomage's Pioneering Pilot-Scale Testing Platform Now Fully Operational, Ushering in New Era of Open Innovation 2024-09-25 21:00
Flat Medical Strengthens Market Leadership with Acquisition of InjeQ Assets, Including FDA-Designated Breakthrough Device IQ-Tip® 2024-09-25 20:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP 2024-09-24 21:00
LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners 2024-09-24 21:00
Noul Demonstrates 'Expert-Level' AI Diagnostic Performance in Europe… Results from Spain's Carlos III Health Institute 2024-09-24 21:00
Bestqool Pro Series Iteration: Upgraded Design for Enhanced User Experience 2024-09-24 21:00
Nona Biosciences Enters Strategic Collaboration with Alkyon Therapeutics for Next-Generation Immunotherapeutics Discovery 2024-09-24 20:00
WuXi Biologics Included in Hang Seng ESG 50 Index 2024-09-23 17:30
Professor Luo Min Appointed as Chairman of Spine Neurocardiology Interdisciplinary Professional Committee in China to Promote Development of Innovative Heart Disease Treatments 2024-09-23 15:06
Gymera Reveal A Breakthrough in Smart Home Fitness and Elderly Wellness Solution at Hong Kong Global Sources Consumer Electronics Show 2024 2024-09-21 18:32
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results 2024-09-21 05:30
Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting 2024-09-20 20:30
Kangpu Completed Bridging Clinical Study of KPG-818 in China 2024-09-20 20:00
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 2024-09-20 16:28
Biosyngen Presents Pioneering"Conditional Activation + Armor Enhancement" SUPER-T technology at ESMO 2024 2024-09-19 20:30
1 18 19 20 21 22 807